End-of-day quote
Korea S.E.
18:00:00 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
58,600
KRW
|
-0.34%
|
|
+0.17%
|
-18.61%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
17,212,500
|
5,643,627
|
5,528,451
|
4,509,789
|
-
|
-
|
Enterprise Value (EV)
2 |
17,126
|
4,208
|
5,528
|
4,310
|
4,012
|
4,482
|
P/E ratio
|
46.8
x
|
46.2
x
|
-
|
-117
x
|
-244
x
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
18.5
x
|
12.4
x
|
15
x
|
18.3
x
|
14.1
x
|
19.5
x
|
EV / Revenue
|
18.4
x
|
9.21
x
|
15
x
|
17.5
x
|
12.5
x
|
19.4
x
|
EV / EBITDA
|
34.7
x
|
29.6
x
|
-
|
-500
x
|
142
x
|
-
|
EV / FCF
|
34.7
x
|
-21.3
x
|
-
|
-7.06
x
|
-26.1
x
|
-
|
FCF Yield
|
2.88%
|
-4.7%
|
-
|
-14.2%
|
-3.83%
|
-
|
Price to Book
|
10.4
x
|
3.24
x
|
-
|
2.67
x
|
2.71
x
|
2.96
x
|
Nbr of stocks (in thousands)
|
76,500
|
76,784
|
76,784
|
76,828
|
-
|
-
|
Reference price
3 |
225,000
|
73,500
|
72,000
|
58,700
|
58,700
|
58,700
|
Announcement Date
|
22-02-07
|
23-02-08
|
24-02-01
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
183.2
|
225.6
|
929
|
456.7
|
369.5
|
245.8
|
320.3
|
231.1
|
EBITDA
1 |
-
|
-
|
493
|
142.3
|
-
|
-8.62
|
28.33
|
-
|
EBIT
1 |
-
|
37.71
|
474.2
|
115
|
-11.99
|
-68.59
|
-45.8
|
-118.8
|
Operating Margin
|
-
|
16.71%
|
51.05%
|
25.18%
|
-3.24%
|
-27.91%
|
-14.3%
|
-51.39%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
471.1
|
141.7
|
7.327
|
-38.36
|
-16.38
|
-
|
Net income
1 |
-
|
-
|
355.1
|
122.5
|
22.32
|
-38.66
|
-18.58
|
-
|
Net margin
|
-
|
-
|
38.23%
|
26.81%
|
6.04%
|
-15.73%
|
-5.8%
|
-
|
EPS
2 |
6,933
|
-
|
4,810
|
1,590
|
-
|
-503.7
|
-240.4
|
-
|
Free Cash Flow
3 |
-
|
-
|
493,686
|
-197,951
|
-
|
-610,000
|
-153,780
|
-
|
FCF margin
|
-
|
-
|
53,141.65%
|
-43,341.33%
|
-
|
-248,184.23%
|
-48,013.1%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
100,140.23%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
139,011.89%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-03-30
|
21-03-23
|
22-02-07
|
23-02-08
|
24-02-01
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
257.3
|
220.8
|
450.9
|
87.09
|
138.3
|
91.05
|
140.3
|
20.6
|
26.48
|
231.8
|
90.6
|
46.55
|
54.15
|
89
|
67
|
EBITDA
|
-
|
-
|
-
|
-
|
67.63
|
-
|
16.56
|
-20.92
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
100.4
|
253.9
|
23.75
|
61.19
|
21.36
|
8.714
|
-29.19
|
-35.31
|
60.94
|
-8.427
|
-18.6
|
-18.35
|
-1.25
|
-6.4
|
Operating Margin
|
-
|
45.47%
|
56.32%
|
27.27%
|
44.25%
|
23.46%
|
6.21%
|
-141.71%
|
-133.35%
|
26.29%
|
-9.3%
|
-39.96%
|
-33.89%
|
-1.4%
|
-9.55%
|
Earnings before Tax (EBT)
1 |
-
|
96.57
|
251.6
|
32.76
|
55.34
|
23.18
|
30.46
|
-25.66
|
-29.24
|
58.62
|
3.605
|
-17.3
|
-18.4
|
-1
|
-4.7
|
Net income
1 |
-
|
76.44
|
184
|
27.81
|
46.13
|
20.78
|
27.74
|
-14.27
|
-15.98
|
48.39
|
4.17
|
-13.2
|
-14
|
-0.7
|
-3.6
|
Net margin
|
-
|
34.61%
|
40.8%
|
31.93%
|
33.36%
|
22.82%
|
19.77%
|
-69.27%
|
-60.34%
|
20.87%
|
4.6%
|
-28.36%
|
-25.85%
|
-0.79%
|
-5.37%
|
EPS
|
1,342
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-08-12
|
21-10-29
|
22-02-07
|
22-04-29
|
22-07-29
|
22-10-31
|
23-02-08
|
23-04-27
|
23-07-28
|
23-10-26
|
24-02-01
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
86.4
|
1,435
|
-
|
200
|
498
|
27.7
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
-
|
-
|
493,686
|
-197,951
|
-
|
-610,000
|
-153,780
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
38.1%
|
7.33%
|
1.3%
|
-2.41%
|
-1.62%
|
-4.31%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
26.6%
|
5.76%
|
-
|
-2.5%
|
-2.08%
|
-
|
Assets
1 |
-
|
-
|
1,336
|
2,126
|
-
|
1,546
|
893.5
|
-
|
Book Value Per Share
3 |
-
|
-
|
21,689
|
22,703
|
-
|
21,997
|
21,661
|
19,844
|
Cash Flow per Share
3 |
-
|
-
|
7,268
|
-1,622
|
-
|
647.0
|
687.0
|
-
|
Capex
1 |
-
|
-
|
42.9
|
73
|
-
|
284
|
171
|
-
|
Capex / Sales
|
-
|
-
|
4.62%
|
15.98%
|
-
|
115.48%
|
53.44%
|
-
|
Announcement Date
|
20-03-30
|
21-03-23
|
22-02-07
|
23-02-08
|
24-02-01
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Mean consensus UNDERPERFORM Last Close Price
58,700
KRW Average target price
58,000
KRW Spread / Average Target -1.19% Consensus |
1st Jan change
|
Capi.
|
---|
| -18.61% | 3.25B | | -3.62% | 86.16B | | +2.76% | 40.17B | | -17.49% | 31.47B | | +54.44% | 25.24B | | -13.13% | 15.82B | | -9.12% | 11.96B | | -15.45% | 11.89B | | -42.56% | 11.61B | | +4.87% | 8.84B |
Biopharmaceuticals
|